Want to see AVIR full AI Analyst Report?
Atea Pharmaceuticals (AVIR) Ownership - Who Owns Atea Pharmaceuticals?
Atea Pharmaceuticals (AVIR) Ownership Overview
- 11.27% Insiders
- 17.45% Mutual Funds
- 0.75% Other Institutional Investors
- 11.77% ETFs
- 58.76% Public Companies and Individual Investors
The ownership structure of Atea Pharmaceuticals (AVIR) stock is a mix of institutional, retail, and individual investors. Approximately 29.97% of the company’s stock is owned by Institutional Investors, 11.27% is owned by Insiders, and 58.76% is owned by Public Companies and Individual Investors.
The ownership structure of Atea Pharmaceuticals (AVIR) stock is a mix of institutional, retail, and individual investors. Approximately 18.20% of the company’s stock is owned by Institutional Investors, 11.27% is owned by Insiders, and 11.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 19, 2026 | Polly A. Murphy | $25,437 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Graham Capital Management, L.p. | $75,074 | |
| Jun 30, 2026 | $40,548,358 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Jean-pierre Sommadossi | 6,633,855 | Insider | 8.27% | 27,265,144 |
| Fidelity Mt. Vernon Street Trust | 5,081,312 | Institution | 6.34% | 20,884,192 |
| Ishares | 3,518,342 | Institution | 4.39% | 14,460,386 |
| Vanguard | 3,479,428 | Institution | 4.34% | 14,300,449 |
| Vanguard Index Funds | 2,897,586 | Institution | 3.61% | 11,909,078 |
| Fidelity Salem Street Trust | 881,709 | Institution | 1.10% | 3,623,824 |
| Andrea Corcoran | 823,576 | Insider | 1.03% | 3,384,897 |
| Dfa | 778,484 | Institution | 0.97% | 3,199,569 |
| Blackrock Funds | 756,182 | Institution | 0.94% | 3,107,908 |
| Fidelity Concord Street Trust | 728,719 | Institution | 0.91% | 2,995,035 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust | 5,081,312 | Institution | 6.34% | 20,884,192 |
| Vanguard Index Funds | 2,897,586 | Institution | 3.61% | 11,909,078 |
| Fidelity Salem Street Trust | 881,709 | Institution | 1.10% | 3,623,824 |
| Blackrock Funds | 756,182 | Institution | 0.94% | 3,107,908 |
| Fidelity Concord Street Trust | 728,719 | Institution | 0.91% | 2,995,035 |
| Dfa Investment Dimensions Group Inc | 690,702 | Institution | 0.86% | 2,838,785 |
| Tiaa-cref Funds | 489,864 | Institution | 0.61% | 2,013,341 |
| Vanguard Scottsdale Funds | 478,112 | Institution | 0.60% | 1,965,040 |
| Fidelity Select Portfolios | 287,662 | Institution | 0.36% | 1,182,291 |
| Jpmorgan Trust I | 243,540 | Institution | 0.30% | 1,000,949 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 2,032,268 | Institution | 2.53% | 10,588,116 |
| iShares | 1,802,201 | Institution | 2.25% | 7,767,486 |
| Vanguard | 806,833 | Institution | 1.01% | 4,203,600 |
| iShares | 665,401 | Institution | 0.83% | 2,867,878 |
| DFA | 613,906 | Institution | 0.77% | 2,645,935 |
| iShares | 505,189 | Institution | 0.63% | 2,076,327 |
| Vanguard | 412,364 | Institution | 0.51% | 2,148,416 |
| Schwab | 372,525 | Institution | 0.46% | 1,605,583 |
| Dimensional | 234,809 | Institution | 0.29% | 1,103,602 |
| iShares | 215,211 | Institution | 0.27% | 927,559 |
FAQ
Who Owns Atea Pharmaceuticals (AVIR)?
According to the latest TipRanks data, approximately 0.75% of the company's stock is held by institutional investors, 11.27% is held by insiders, and 58.76% is held by retail investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.75% of Atea Pharmaceuticals (AVIR) stock is held by institutional investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.76% of Atea Pharmaceuticals (AVIR) stock is held by retail investors.
Who owns the most shares of Atea Pharmaceuticals (AVIR)?
Jean-Pierre Sommadossi owns the most shares of Atea Pharmaceuticals (AVIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.